Correlative immunohistochemistry and molecular genetic study of the inactivation of the p16(INK4A) genes in astrocytomas

Diagnostic Molecular Pathology

Volumn 6, Issue 2, 1997, Pages 115-122

  Rao, Laxmi S ^a   Miller, Douglas C ^b   Newcomb, Elizabeth W ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Astrocytoma; Immunohistochemistry; p16 gene; Tumor progression

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P16; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CHILD; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0030909375     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199704000-00008     Document Type: Article

References (32)

1. Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang H-JS. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 1995;55:1351-4.
2. Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994;265:415-416.
3. Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res 1995;55:984-988.
4. INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 1995;55:6006-6011.
5. Giani C, Finocchiaro G. Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res 1994;54:6338-9.
6. Gonzalez-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995;55:4531-5.
7. Haermanson M, Funa K, Koopman J, et al. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor α receptor expression in human malignant gliomas. Cancer Res 1996;56:164-171.
8. INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of CDK4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 1995;55:4833-4836.
9. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-4530.
10. Jen J, Harper JW, Bigner SH, et al. Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994;54:6353-6358.
11. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-440.
12. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system. New York: Springer-Verlag 1993.
13. Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994;81:427-436.
14. Li Y, Bollag G, Clark R, et al. Somatic mutation in the neurofibromatosis 1 gene in human tumors. Cell 1992;69:275-281.
15. Li Y-J, Hoang-Xuan K, Delattre J-Y, Poisson M, Thomas G, Hamelin R. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas. Oncogene 1995;11:597-600.
16. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1995;1:686-692.
17. Moulton T, Samara G, Chung W-Y, et al. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Am J Pathol 1995;146:613-619.
18. INK4 expression is frequent in high grade gliomas. Cancer Res 1995; 55:1941-1945.
19. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-756.
20. Ohgaki H, Schauble B, zur Hausen A, von Ammon K, Kleihues P. Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch 1995; 427:113-118.
21. INK4 protein induction by 5-aza 2′deoxycytidine. Oncogene 1995;11:1211-1216.
22. Reed JA, Loganzo F, Shea CR, et al. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 1995;55:2713-2718.
23. Schmidt EE, Ichimura K, Reifenberger G, Collins VP. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994;54:6321-6324.
24. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-707.
25. INK4A inactivation in non-small lung cancer cell lines. Cancer Res 1995;55:6200-6209.
26. Sonoda Y, Yoshimoto T, Sekiga T. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Oncogene 1995;11:2145-2149.
27. Spruck CH III, Gonzalez-Zulueta M, Shibata A, et al. p16 gene in uncultured tumors. Nature 1994;370:183-184.
28. Ueki K, Rubio M-P, Ramesh V, et al. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet 1994;3:1841-1845.
29. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 1996;56:150-153.
30. von Diemling A, von Ammon K, Schoenfeld DA, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis: Brain Pathol 1993;3:19-26.
31. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 1995;55:20-23.
32. Westermark B, Nister M. Molecular genetics of human glioma. Curr Opin Oncol 1995;7:220-225.